Literature DB >> 27631758

Tuberculosis in Jails and Prisons: United States, 2002-2013.

Lauren A Lambert1, Lori R Armstrong1, Mark N Lobato1, Christine Ho1, Anne Marie France1, Maryam B Haddad1.   

Abstract

OBJECTIVES: To describe cases and estimate the annual incidence of tuberculosis in correctional facilities.
METHODS: We analyzed 2002 to 2013 National Tuberculosis Surveillance System case reports to characterize individuals who were employed or incarcerated in correctional facilities at time they were diagnosed with tuberculosis. Incidence was estimated with Bureau of Justice Statistics denominators.
RESULTS: Among 299 correctional employees with tuberculosis, 171 (57%) were US-born and 82 (27%) were female. Among 5579 persons incarcerated at the time of their tuberculosis diagnosis, 2520 (45%) were US-born and 495 (9%) were female. Median estimated annual tuberculosis incidence rates were 29 cases per 100 000 local jail inmates, 8 per 100 000 state prisoners, and 25 per 100 000 federal prisoners. The foreign-born proportion of incarcerated men 18 to 64 years old increased steadily from 33% in 2002 to 56% in 2013. Between 2009 and 2013, tuberculosis screenings were reported as leading to 10% of diagnoses among correctional employees, 47% among female inmates, and 42% among male inmates.
CONCLUSIONS: Systematic screening and treatment of tuberculosis infection and disease among correctional employees and incarcerated individuals remain essential to tuberculosis prevention and control.

Entities:  

Mesh:

Year:  2016        PMID: 27631758      PMCID: PMC5104991          DOI: 10.2105/AJPH.2016.303423

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  23 in total

1.  Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-09       Impact factor: 17.586

2.  Methodological issues in quantifying the magnitude of the tuberculosis problem in a prison population.

Authors:  H L Rieder; C Anderson; M Dara; B Hauer; P Helbling; K M Kam; M Zwahlen
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

3.  Incidence of tuberculosis infection among New York State prison employees.

Authors:  K Steenland; A J Levine; K Sieber; P Schulte; D Aziz
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

4.  The Rikers Island Hot Spotters: Defining the Needs of the Most Frequently Incarcerated.

Authors:  Ross MacDonald; Fatos Kaba; Zachary Rosner; Allison Vise; David Weiss; Mindy Brittner; Molly Skerker; Nathaniel Dickey; Homer Venters
Journal:  Am J Public Health       Date:  2015-09-17       Impact factor: 9.308

5.  Tuberculosis control: lessons for outbreak preparedness in correctional facilities.

Authors:  Farah M Parvez; Mark N Lobato; Robert B Greifinger
Journal:  J Correct Health Care       Date:  2010-05-12

6.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

7.  Tuberculosis in a correctional facility.

Authors:  A R Pelletier; G T DiFerdinando; A J Greenberg; D M Sosin; W D Jones; A B Bloch; C L Woodley
Journal:  Arch Intern Med       Date:  1993-12-13

8.  Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991.

Authors:  S E Valway; S B Richards; J Kovacovich; R B Greifinger; J T Crawford; S W Dooley
Journal:  Am J Epidemiol       Date:  1994-07-15       Impact factor: 4.897

9.  Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

Authors:  E E Bliven-Sizemore; T R Sterling; N Shang; D Benator; K Schwartzman; R Reves; J Drobeniuc; N Bock; M E Villarino
Journal:  Int J Tuberc Lung Dis       Date:  2015-09       Impact factor: 2.373

10.  Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail.

Authors:  Maria Juarez-Reyes; Mark Gallivan; Alexander Chyorny; Linda O'Keeffe; Neha S Shah
Journal:  Open Forum Infect Dis       Date:  2016-01-06       Impact factor: 3.835

View more
  19 in total

1.  Changes in Tuberculosis Disparities at a Time of Decreasing Tuberculosis Incidence in the United States, 1994-2016.

Authors:  Awal Khan; Suzanne Marks; Dolly Katz; Sapna Bamrah Morris; Lauren Lambert; Elvin Magee; Sloane Bowman; Gail Grant
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

Review 2.  Mass Incarceration and Pulmonary Health: Guidance for Clinicians.

Authors:  Elizabeth M Viglianti; Theodore J Iwashyna; Tyler N A Winkelman
Journal:  Ann Am Thorac Soc       Date:  2018-04

3.  High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons.

Authors:  Kristine M Schmit; Mark N Lobato; Simona G Lang; Sherri Wheeler; Newton E Kendig; Sarah Bur
Journal:  J Public Health Manag Pract       Date:  2019 Mar/Apr

4.  Tuberculosis trends in California correctional facilities, 1993-2013.

Authors:  C J McDaniel; A S Chitnis; P M Barry; N Shah
Journal:  Int J Tuberc Lung Dis       Date:  2017-08-01       Impact factor: 2.373

Review 5.  Epidemiology of Tuberculosis in the United States.

Authors:  Adam J Langer; Thomas R Navin; Carla A Winston; Philip LoBue
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

6.  Tuberculosis Outbreaks in State Prisons, United States, 2011-2019.

Authors:  Rebekah J Stewart; Kala M Raz; Scott P Burns; J Steve Kammerer; Maryam B Haddad; Benjamin J Silk; Jonathan M Wortham
Journal:  Am J Public Health       Date:  2022-08       Impact factor: 11.561

Review 7.  Occupational Respiratory Infections.

Authors:  Marie A de Perio; Miwako Kobayashi; Jonathan M Wortham
Journal:  Clin Chest Med       Date:  2020-12       Impact factor: 2.878

8.  Risk of COVID-19 infection among prison staff in the United States.

Authors:  Kathryn M Nowotny; Kapriske Seide; Lauren Brinkley-Rubinstein
Journal:  BMC Public Health       Date:  2021-06-02       Impact factor: 3.295

9.  Mitigating outbreaks in congregate settings by decreasing the size of the susceptible population.

Authors:  Seth Blumberg; Phoebe Lu; Christopher M Hoover; James O Lloyd-Smith; Ada T Kwan; David Sears; Stefano M Bertozzi; Lee Worden
Journal:  medRxiv       Date:  2021-07-07

10.  Is There a Temporal Relationship between COVID-19 Infections among Prison Staff, Incarcerated Persons and the Larger Community in the United States?

Authors:  Danielle Wallace; John M Eason; Jason Walker; Sherry Towers; Tony H Grubesic; Jake R Nelson
Journal:  Int J Environ Res Public Health       Date:  2021-06-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.